Home

Entero Therapeutics Inc. - Common Stock (ENTO)

0.5240
+0.0240 (4.80%)

Entero Therapeutics Inc. is a biopharmaceutical company focused on developing innovative therapies for gastrointestinal disorders and related health conditions

The company is dedicated to advancing its proprietary drug delivery technologies and treatment strategies that target the gastrointestinal tract, aiming to improve the lives of patients with challenging medical issues. Through rigorous research and development, Entero is committed to addressing unmet medical needs in the field of digestive health and enhancing the effectiveness of existing therapies.

SummaryNewsPress ReleasesChartHistoricalFAQ

Frequently Asked Questions

Is Entero Therapeutics Inc. - Common Stock publicly traded?
Yes, Entero Therapeutics Inc. - Common Stock is publicly traded.
What exchange does Entero Therapeutics Inc. - Common Stock trade on?
Entero Therapeutics Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Entero Therapeutics Inc. - Common Stock?
The ticker symbol for Entero Therapeutics Inc. - Common Stock is ENTO on the Nasdaq Stock Market
What is the current price of Entero Therapeutics Inc. - Common Stock?
The current price of Entero Therapeutics Inc. - Common Stock is 0.5240
When was Entero Therapeutics Inc. - Common Stock last traded?
The last trade of Entero Therapeutics Inc. - Common Stock was at 1:27 pm EST on January 31st, 2025